Gareev, I,
Gileva, Y,
Dzidzaria, A,
Beylerli, O,
Pavlov, V,
Agaverdiev, M,
Mazorov, B,
Biganyakov, I,
Vardikyan, A,
Jin, M,
Ahmad, A (2021) For several decades, research in tumor biology has
focused on the involvement of genes encoding a
within the cardiovascular landscape. This review
focuses on “immuno-miRs,” a class of mi
promising
targets for therapeutic intervention. This review explores the potential of polyphenols, a diverse
Yao, JW,
Du, YM,
Liu, JS,
Gareev, I,
Yang, G,
Kang, XH,
Wang, XX,
Beylerli, O,
Chen, X (2021) , we mainly
focus on the HIF-related lncRNA which regulates the expression of HIF or is regulated
Enikeeva, Kadriia,
Rafikova, Guzel,
Sharifyanova, Yuliya,
Mulyukova, Diana,
Vanzin, Alexandr,
Pavlov, Valentin (2024) to
focus on the development of effective diagnostic and therapeutic approaches. Due to the development
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) the primary research pathways in the development of new anti-cancer medications, with a particular
focusSufianov, Albert,
Beilerli, Aferin,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Wenjie, Bu,
Beylerli, Ozal (2023) of therapeutic biomolecules to their
target is a challenging issue, which can be solved by innovations in drug